PROSPECTIVE URODYNAMIC EVALUATION OF THE EFFICACY OF PROSTATIC BALLOON DILATATION

被引：5

作者：

GANABATHI, K ^{[1
]}

ROSKAMP, D ^{[1
]}

FOOTE, J ^{[1
]}

ZIMMERN, PE ^{[1
]}

LEACH, GE ^{[1
]}

机构：

[1] KAISER PERMANENTE MED CTR,DEPT UROL & URODYNAM,4900 SUNSET BLVD,LOS ANGELES,CA 90027

来源：

NEUROUROLOGY AND URODYNAMICS | 1992年 / 11卷 / 05期

关键词：

OUTFLOW OBSTRUCTION; BENIGN PROSTATIC HYPERPLASIA; BALLOON DILATATION TREATMENT;

D O I：

10.1002/nau.1930110504

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In order to evaluate the ability of transurethral prostatic balloon dilatation (TUPBD) to effectively treat prostatic obstruction, 18 men (aged 53-77 years) with obstructive small prostate glands were evaluated with symptom scores and urodynamic studies before and 6 and 12 months after TUPBD utilizing the endoscopically placed Advanced Surgical Intervention 75F balloon. After TUPBD, 81% of men reported some improvement in their symptoms with statistical significance (P < .05) at 6 and 12 months after the procedure. The mean non-invasive peak flow rate did not change significantly after TUPBD. Although the mean maximum voiding pressure (Pq max) and the maximum detrusor pressure at peak flow (Pq max) were reduced at 6 and 12 months postoperatively, the changes were found to be statistically insignificant (P > .05). In addition, the use of Abrams and Griffiths pressure-flow nomogram revealed a "non-obstructive" pressure-flow study in only one patient at 6 and 12 after TUPBD. Although TUPBD results in some symptomatic improvement, on pressure-flow analysis the majority of men remain obstructed at 6 and 12 months after the procedure.

引用

页码：483 / 495

页数：13

共 53 条

[1]

Abrams PH, Griffiths DJ, The assessment of prostatic obstruction from urodynamic measurements and from residual urine, Br J Urol, 51, pp. 129-132, (1979)

[2]

Abrams PH, Shah PJ, Stone R, Choa RG, Bladder outflow obstruction treated with phenoxybenzamine, Br J Urol, 54, pp. 527-530, (1982)

[3]

Abrams P, Lewis P, Gillatt D, Balloon dilatation in BPH under endoscopic control, J Urol Part 2, 141, (1989)

[4]

Ball AJ, Feneley RCL, Abrams PH, The natural history of prostatism, Br J Urol, 53, pp. 613-616, (1981)

[5]

Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH, Natural history of benign prostatic hypertrophy and acute urinary retention, Urology, 7, pp. 48-52, (1976)

[6]

Blaivas JG, Multichannel urodynamic studies in men with benign prostatic hyperplasia, Urol Clin North Am, 17, pp. 537-542, (1990)

[7]

Burnnhenne HJ, Chisholm RJ, Grenville NJ, Prostatic hyperplasia: Radiologic intervention, Radiology, 152, pp. 655-657, (1984)

[8]

Casteneda F, Reddy P, Wasserman N, Hulbert J, Lund G, Letourneau JG, Hunter DW, Casteneda-Zuniga WR, Amplatz K, Benign prostatic hypertrophy, retrograde transurethral dilation of the prostatic urethra in humans. Wor. in progress, Radiology, 163, pp. 649-653, (1987)

[9]

Castro JE, Griffiths HJL, Shackman R, Significance of signs and symptoms in benign prostatic hypertrophy, Br Med J [Clin Res], 2, pp. 598-601, (1969)

[10]

Castro JE, Griffiths HJL, Edwards DE, A double blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy, Br J Urol, 58, pp. 485-489, (1971)

← 1 2 3 4 5 6 →